Real-time enrollment status for this metabolic dysfunction-associated steatohepatitis clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:25 PM UTC
| NCT Number | NCT07288138 |
| Recruiting Status | Recruiting |
| Condition | Metabolic Dysfunction-associated Steatohepatitis |
| Phase | PHASE2 |
| Target Enrollment | 160 participants |
| Active Locations | 63 sites in the US |
| Sponsor | Eccogene |
| Last Updated on CT.gov | August 6, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT07288138 is currently recruiting participants. This phase2 study for metabolic dysfunction-associated steatohepatitis is actively seeking new participants at 63 locations across the United States. The study is sponsored by Eccogene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07288138 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07288138 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.